# Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

> **NCT01814397** · — · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer
- Pain
- Arthralgia

## Interventions

- **DRUG:** Anastrozole
- **DRUG:** exemestane
- **DRUG:** letrozole

## Key facts

- **NCT ID:** NCT01814397
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-07
- **Final completion:** 2013-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814397, "Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01814397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*